Alector (ALEC) Amortizatization of Intangibles (2018 - 2026)
Alector (ALEC) reported Amortizatization of Intangibles of $667000.0 for Q1 2026, down 22.8% year-over-year from $864000.0 in Q1 2025, and down 46.47% on a QoQ basis from $1.2 million in Q4 2025.
Alector (ALEC) has 9 years of Amortizatization of Intangibles data on file, last reported at $667000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 22.8% year-over-year to $667000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (down 40.15% YoY) and the FY2025 annual result came in at $6.6 million, down 54.25% from the prior year.
- Amortizatization of Intangibles retreated to $667000.0 in Q1 2026 per ALEC's latest filing, from $1.2 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $11.8 million in Q4 2024 and bottomed at -$2.9 million in Q2 2024.
- The 5-year median for Amortizatization of Intangibles is $821000.0 (2023), against an average of $1.6 million.
- Peak annual rise in Amortizatization of Intangibles reached 1334.96% in 2024, while the deepest fall reached 472.1% in 2024.
- Tracing ALEC's Amortizatization of Intangibles over 5 years: stood at $719000.0 in 2022, then grew by 14.19% to $821000.0 in 2023, then surged by 1334.96% to $11.8 million in 2024, then sank by 89.42% to $1.2 million in 2025, then slumped by 46.47% to $667000.0 in 2026.
- Per Business Quant, the three latest ALEC Amortizatization of Intangibles figures stand at $667000.0 (Q1 2026), $1.2 million (Q4 2025), and $1.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Alector | 238.87 Mn | 32.36 Mn | - | 667,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 667,000.00 |
| Mar 31, 2026 | 667,000.00 |
| Dec 31, 2025 | 1.25 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 864,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Dec 31, 2024 | 11.78 Mn |
| Dec 31, 2024 | 11.78 Mn |
| Sep 30, 2024 | 873,000.00 |
| Sep 30, 2024 | 873,000.00 |
| Jun 30, 2024 | -2.85 Mn |
| Jun 30, 2024 | -2.85 Mn |
| Mar 31, 2024 | 4.58 Mn |
| Mar 31, 2024 | 4.58 Mn |
| Dec 31, 2023 | 821,000.00 |
| Dec 31, 2023 | 821,000.00 |
| Sep 30, 2023 | 793,000.00 |
| Sep 30, 2023 | 793,000.00 |
| Jun 30, 2023 | 767,000.00 |
| Jun 30, 2023 | 767,000.00 |
| Mar 31, 2023 | 742,000.00 |
| Mar 31, 2023 | 742,000.00 |
| Dec 31, 2022 | 719,000.00 |
| Dec 31, 2022 | 719,000.00 |
| Sep 30, 2022 | 2.76 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | -1.39 Mn |
| Jun 30, 2022 | -1.39 Mn |
| Mar 31, 2022 | 670,000.00 |
| Mar 31, 2022 | 670,000.00 |
| Dec 31, 2021 | 552,000.00 |
| Dec 31, 2021 | 552,000.00 |
| Sep 30, 2021 | 496,000.00 |
| Sep 30, 2021 | 496,000.00 |
| Jun 30, 2021 | 477,000.00 |
| Jun 30, 2021 | 477,000.00 |
| Mar 31, 2021 | 461,000.00 |
| Mar 31, 2021 | 461,000.00 |
| Dec 31, 2020 | -576,000.00 |
| Dec 31, 2020 | -576,000.00 |
| Sep 30, 2020 | -258,000.00 |
| Sep 30, 2020 | -258,000.00 |
| Jun 30, 2020 | 10,000.00 |
| Jun 30, 2020 | 10,000.00 |
| Mar 31, 2020 | 240,000.00 |
| Mar 31, 2020 | 240,000.00 |
| Dec 31, 2019 | 289,000.00 |
| Dec 31, 2019 | 289,000.00 |
| Sep 30, 2019 | -1.35 Mn |
| Sep 30, 2019 | -1.35 Mn |
| Jun 30, 2019 | 2.09 Mn |
| Jun 30, 2019 | 2.09 Mn |
| Mar 31, 2019 | 768,000.00 |
| Mar 31, 2019 | 768,000.00 |
| Dec 31, 2018 | 967,000.00 |
| Dec 31, 2018 | 967,000.00 |
| Sep 30, 2018 | 825,000.00 |
| Sep 30, 2018 | 825,000.00 |
| Jun 30, 2018 | 601,000.00 |
| Jun 30, 2018 | 601,000.00 |
| Mar 31, 2018 | 352,000.00 |
| Mar 31, 2018 | 352,000.00 |